Expression of tissue factor pathway inhibitor 2 in human pancreatic carcinoma and its effect on tumor growth, invasion, and migration in vitro and in vivo

Journal of Surgical Research

Volumn 167, Issue 1, 2011, Pages 62-69

  Tang, Zhigang ^a   Geng, Guangyong ^a   Huang, Qiang ^a   Xu, Geliang ^a   Hu, Hejie ^a   Chen, Jiong ^a   Li, Jiansheng ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

pancreatic carcinoma; TFPI 2; tissue factor pathway inhibitor 2

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; MATRIGEL; PLACENTA PROTEIN 5;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER TISSUE; CELL MIGRATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; AGED; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREAS; PANCREATIC NEOPLASMS; RNA, MESSENGER; TRANSFECTION;

EID: 79953056882     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.06.015     Document Type: Article

References (30)

1. S. Fazal, and M.W. Saif Supportive and palliative care of pancreatic cancer JOP 8 2007 240
2. J. Westermarck, and V.M. Kahari Regulation of matrix metalloproteinase expression in tumor invasion FASEB J 13 1999 781
3. C.C. Lynch, and L.M. Matrisian Matrix metalloproteinases in tumor-host cell communication Differentiation 70 2002 561
4. V. Ellenrieder, G. Adler, and T.M. Gress Invasion and metastasis in pancreatic cancer Ann Oncol 10 1999 46
5. M. Hirata, T. Sato, and M. Tsumagari Discoordinate regulation of expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases-3 in bovine endometrial stromal cells on type-I collagen gel Biol Pharm Bull 26 2003 1013
6. Y. Miyagi, H. Yasumitsu, and T. Eki Assignment of the human PP5/TFPI-2 gene to 7q22 by FISH and PCR-based human/rodent cell hybrid mapping panel analysis Genomics 35 1996 67
7. R. Bützow, M.L. Huhtala, and H. Bohn Purification and characterization of placental protein 5 Biochem Biophys Res Commun 150 1988 483
8. C.A. Sprecher, W. Kisiel, and S. Mathewes Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor Proc Natl Acad Sci USA 91 1994 3353
9. C.N. Rao, P. Reddy, and Y.Y. Liu Extracellular matrix-associated serine protease inhibitors (M 33,000, 31,000 and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2 Arch Biochem Biophys 335 1996 82
10. C.N. Rao, B. Cook, and Y. Liu HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI Int J Cancer 76 1998 749
11. H. Izumi, C. Takahashi, and J. Oh Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes FEBS Lett 481 2000 31
12. M. Jin, K. Udagawa, and E. Miyagi Expression of serine proteinase inhibitor PP5/TFPI-2/MSPI decreases the invasive potential of human choriocarcinoma cells in vitro and in vivo Gynecol Oncol 83 2001 25
13. S.D. Konduri, C.N. Rao, and N. Chandrasekar A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion Oncogene 20 2001 6938
14. L.H. Sobin, and I.D. Fleming TNM classification of malignant tumors, fifth edition (1997) Cancer 80 1997 1803
15. Q. Meng, M. Qi, and D.Z. Chen Suppression of breast cancer invasion and migration by indole-3-carbinol: Associated with upregulation of BRCA1 and E-cadherin/catenin complexes J Mol Med 78 2001 155
16. C.J. Bruns, M.T. Harbison, and H. Kuniyasu In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice Neoplasia 1 1999 50
17. D.L. Crowe, and C.F. Shuler Regulation of tumor cell invasion by extracellular matrix Histol Histopathol 14 1999 665
18. L.J. McCawley, and L.M. Matrisian Matrix metalloproteinases: Multifunctional contributors to tumor progression Mol Med Today 6 2000 149
19. K. Nabeshima, T. Inoue, and Y. Shimao Matrix metalloproteinases in tumor invasion: Role for cell migration Pathol Int 52 2002 255
20. F. Hubé, P. Reverdiau, and S. Iochmann Computer model of the interaction of human TFPI-2 kunitz-type serine protease inhibitor with human plasmin Thromb Res 111 2003 197
21. S. Siegling, E. Thyzel, and T. Brinkmann Genetic variation in the human TFPI-2 gene and its promoter region by denaturing high performance liquid chromatography Thromb Res 113 2004 341
22. H.S. Chand, A.E. Schmidt, and S.P. Bajaj Structure-function analysis of the reactive site in the first kunitz-type domain of human tissue factor pathway inhibitor-2 J Biol Chem 279 2004 17500
23. C.N. Rao, C.L. Peavey, and Y.Y. Liu Partial characterization of matrix-associated serine protease inhibitors from human skin cells J Invest Dermatol 104 1995 379
24. Y. Liu, S.M. Stack, and S.S. Lakka Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: Heparin accelerates the activity of TFPI-2/MSPI toward plasmin Arch Biochem Biophys 370 1999 112
25. C.N. Rao, S. Mohanam, and A. Puppala Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor Biochem Biophys Res Commun 255 1999 94
26. J. Rollin, S. Iochmann, and C. Bléchet Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer Br J Cancer 92 2005 775
27. N. Yanamandra, S. Kondraganti, and C.S. Gondi Recombinant adeno-associated virus (rAAV) expressing TFPI-2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line Int J Cancer 115 2005 998
28. S. Kondraganti, C.S. Gondi, and M. Gujrati Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line Int J Oncol 29 2006 25
29. S.D. Konduri, A. Tasiou, and N. Chandrasekar Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion Clin Exp Metastasis 18 2000 303
30. H.S. Chand, X. Du, D. Ma, and H.D. Inzunza The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice Blood 103 2004 1069